P/E ratio for Haemonetics (HAE)

P/E ratio history for Haemonetics from 2001 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Thermo Fisher Scientific TMO	33.0	35.61%	🇺🇸 USA
Stryker Corporation SYK	47.2	93.83%	🇺🇸 USA
Becton Dickinson BDX	34.8	42.96%	🇺🇸 USA
Cerus CERS	-25.9	-206.22%	🇺🇸 USA
Baxter BAX	-28.1	-215.32%	🇺🇸 USA
PerkinElmer PKI	15.0	-38.56%	🇺🇸 USA
Johnson & Johnson JNJ	19.3	-20.59%	🇺🇸 USA
Medtronic MDT	27.9	14.63%	🇮🇪 Ireland

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.